NCT00396682View on ClinicalTrials.gov

Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Advanced HCC
Interventions
DRUG

Cyclophosphamide

150 - 250 - 350 mg

Trial Locations (1)

30655

Medizinische Hochschule Hannover, Hanover

All Listed Sponsors
lead

Hannover Medical School

OTHER

NCT00396682 - Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter